Co-Authors
This is a "connection" page, showing publications co-authored by Xuping Xie and Chao Shan.
Connection Strength
1.209
-
Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach. J Virol. 2018 11 01; 92(21).
Score: 0.198
-
Small Molecules and Antibodies for Zika Therapy. J Infect Dis. 2017 12 16; 216(suppl_10):S945-S950.
Score: 0.187
-
A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun. 2017 09 22; 8(1):676.
Score: 0.184
-
A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients. EBioMedicine. 2017 Mar; 17:157-162.
Score: 0.177
-
Reverse Genetics of Zika Virus. Methods Mol Biol. 2017; 1602:47-58.
Score: 0.175
-
Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses. Antiviral Res. 2020 10; 182:104874.
Score: 0.056
-
Fragile X mental retardation protein is a Zika virus restriction factor that is antagonized by subgenomic flaviviral RNA. Elife. 2018 12 04; 7.
Score: 0.050
-
Potential Mechanisms for Enhanced Zika Epidemic and Disease. ACS Infect Dis. 2018 05 11; 4(5):656-659.
Score: 0.047
-
Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants. PLoS One. 2018; 13(1):e0189262.
Score: 0.047
-
Functional Analysis of Glycosylation of Zika Virus Envelope Protein. Cell Rep. 2017 Oct 31; 21(5):1180-1190.
Score: 0.046
-
A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine. EBioMedicine. 2017 Mar; 17:145-156.
Score: 0.044